Olema Pharmaceuticals Inc (OLMA) — Strategic Asset Allocation Index
Olema Pharmaceuticals Inc (OLMA) has a Strategic Asset Allocation Index of 0.8% as of June 2023. Strategic assets (PP&E of $1.27 Million plus long-term investments of $-) total $1.27 Million, measured against net assets of $161.58 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see OLMA stock market capitalisation.
SAAI
Strategic Assets
PP&E
Net Assets
Olema Pharmaceuticals Inc Strategic Asset Allocation Index (2020–2022)
This chart shows how Olema Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the index stands at 0.8%, representing strategic assets of $1.27 Million against net assets of $161.58 Million USD. See Olema Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Olema Pharmaceuticals Inc (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Olema Pharmaceuticals Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore OLMA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.7% | $1.48 Million | $1.48 Million | $- | $197.55 Million | ▼ -0.9 pp |
| 2021 | 1.7% | $4.72 Million | $4.72 Million | $- | $284.57 Million | ▲ +1.6 pp |
| 2020 | 0.0% | $75.00K | $75.00K | $- | $338.14 Million | — |